Most Read Articles
29 Mar 2020
Targeting a low-density lipoprotein cholesterol level <70 mg/dL following an ischaemic stroke of atherosclerotic origin helps to avoid one in four subsequent major vascular events without increasing the risk of intracranial haemorrhage over about 5 years of follow-up, according to data from the Treat Stroke to Target trial.
Pearl Toh, 12 Sep 2020
Early initiation of rhythm-control therapy led to a significantly reduced risk of major adverse cardiovascular (CV) outcomes compared with usual care (typically rate control) in patients with newly diagnosed atrial fibrillation (AF) at risk of stroke, reveals the EAST-AFNET 4* trial presented at ESC 2020.
Audrey Abella, 16 Sep 2020
The final results of EVAPORATE* reinforce the plaque-regressing potential of icosapent ethyl (IPE) in patients on statins for elevated triglycerides.
01 Feb 2020
High-intensity statin therapy appears to be seeing increased use in patients with acute coronary syndrome and leads to better lipid control, according to a recent Thailand study.

KL cardiac hospital celebrates new MSQH accreditation

Rachel Soon
Medical Writer
27 Dec 2019
Tan Sri Dato’ Dr Yahya Awang, CVSKL chairman (4th from left) receives the hospital’s official MSQH accreditation certificate from Prof Dr Kadar Marikar, MSQH CEO (3rd from right).

The 2-year-old Cardiac Vascular Sentral Kuala Lumpur (CVSKL) has received an accreditation by the Malaysian Society for Quality in Health (MSQH) for the next 4 years.

According to Tan Sri Dato’ Dr Yahya Awang, CVSKL chairman, the accreditation would give a boost to the hospital’s efforts to strengthen Malaysia’s standing as a destination for medical tourism from overseas.

“Gaining accreditation from MSQH is something CVSKL can be proud of because it means we have maintained the best services and is in line with our mission statement—to provide the best patient outcome and experience for each patient, every time,” said Yahya.

Yahya added that the accreditation was a timely achievement as 2020 had been declared the Malaysia Year of Healthcare Travel (MyHT2020) by the Malaysia Healthcare Travel Council (MHTC), an initiative launched by the Ministry of Finance.

The MSQH Hospital Accreditation Programme provides a means for healthcare organisations (HCOs) to assess themselves against the MSQH Hospital Accreditation Standards, a set of national standards developed by veteran healthcare professionals and are accepted as suitable for application throughout Malaysia. The Standards provide a benchmark for regular assessment of organizational performance by HCOs to enable their improvement on an ongoing basis.

“MSQH standards are developed and edited in cooperation with professionals from both public and private healthcare providers, as well as consumers. They are reviewed and updated in light of advances in healthcare,” said Yahya.

Speaking at the accreditation recognition ceremony with Yahya, Associate Professor Dr Kadar Marikar, MSQH chief executive officer, affirmed that the accreditation is intended to provide assurance to local and international patients of CVSKL’s compliance with the latest healthcare standards.

Also present as witnesses at the ceremony were Dolly Lim, MHTC chief operating officer, and Timothy Chang, CVSKL chief executive officer.

“We receive a high volume of international patients due to our proximity to KL Sentral, which positions us in line with MHTC’s goal to make Malaysia a cardiology hub,” said Chang. “With MHTC’s continuous support, we are anticipating a higher volume of patients next year.”

According to a press statement issued by CVSKL, 9 percent of the hospital’s patients in 2019 were international visitors. In anticipation of the MyHT2020 campaign next year, CVSKL expressed confidence that it would be able to increase that figure to 15 percent in 2020, with more than half of international visitors expected to arrive from Indonesia.

The hospital has also pledged to continue working closely with MHTC in its efforts to position Malaysia as a preferred cardiology hub among international visitors.

The MHTC is currently focused on Indonesia as a significant target market for medical tourism services due to its proximity and population size. According to the MHTC’s recent reports, 60 percent of international patients in Malaysian healthcare facilities were from Indonesia, with a steady year-on-year growth of 12 to 18 percent. In 2018 alone, more than 670,000 Indonesian visitors were treated in the combined outpatient and inpatient departments of local private facilities. [Available at: www.mhtc.org.my/mhtc/2019/02/16/60-of-foreign-patients-in-malaysia-come-from-indonesia]

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Cardiology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
29 Mar 2020
Targeting a low-density lipoprotein cholesterol level <70 mg/dL following an ischaemic stroke of atherosclerotic origin helps to avoid one in four subsequent major vascular events without increasing the risk of intracranial haemorrhage over about 5 years of follow-up, according to data from the Treat Stroke to Target trial.
Pearl Toh, 12 Sep 2020
Early initiation of rhythm-control therapy led to a significantly reduced risk of major adverse cardiovascular (CV) outcomes compared with usual care (typically rate control) in patients with newly diagnosed atrial fibrillation (AF) at risk of stroke, reveals the EAST-AFNET 4* trial presented at ESC 2020.
Audrey Abella, 16 Sep 2020
The final results of EVAPORATE* reinforce the plaque-regressing potential of icosapent ethyl (IPE) in patients on statins for elevated triglycerides.
01 Feb 2020
High-intensity statin therapy appears to be seeing increased use in patients with acute coronary syndrome and leads to better lipid control, according to a recent Thailand study.